Hey, thanks for the post. I learn something new and fascinating every day.
Memantine has been a big clinical disappointment in my practice with Alzheimer's disease and I still can't understand why the manufacturer hasn't spent more attention and money on trials with tramatic brain injured patients (particularly with the huge number of TBI patients coming back from Iraq.)
I'm glad to see some real data on neuroprotective effects, even if it's just monkeys.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.